What is the pathogenesis of antepartum hemorrhage?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: November 5, 2026 • View editorial policy

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.

Pathogenesis of Antepartum Hemorrhage

Antepartum hemorrhage (APH) results from two primary pathophysiologic mechanisms: abnormal placentation (placenta praevia and placenta accreta spectrum) and premature placental separation (abruption), with emerging evidence identifying ascending infection/chorioamnionitis as a significant third pathway.

Primary Pathophysiologic Mechanisms

Placenta Praevia

The fundamental pathogenesis involves abnormal implantation of the placenta in the lower uterine segment, either partially or completely covering the internal cervical os 1. This occurs due to:

  • Defective decidualization in the lower uterine segment, often related to prior uterine scarring (previous cesarean sections, curettage)
  • Inadequate vascular supply in the upper uterine segment, causing the placenta to seek alternative implantation sites
  • Trophoblastic tissue extending beyond normal boundaries to compensate for poor blood supply

The bleeding mechanism in placenta praevia results from:

  • Mechanical disruption of placental attachment as the lower uterine segment develops and thins in the third trimester
  • Cervical effacement and dilation causing shearing forces at the placental-uterine interface
  • Inability of the lower segment to contract effectively to compress bleeding vessels, unlike the upper uterine segment

Short cervical length (<31 mm) increases hemorrhage risk 16-fold by indicating earlier cervical changes and mechanical disruption 1.

Placenta Accreta Spectrum

This represents abnormally invasive placentation where chorionic villi penetrate beyond the normal decidual plane 2:

  • Placenta accreta: Villi attach directly to myometrium (absent decidua basalis)
  • Placenta increta: Villi invade into myometrium
  • Placenta percreta: Villi penetrate through serosa, potentially into adjacent organs

The pathogenesis involves:

  • Deficient or absent decidua basalis at the implantation site (typically previous cesarean scar)
  • Excessive trophoblastic invasion through areas of uterine wall weakness
  • Abnormal vascular remodeling creating high-flow, low-resistance vessels prone to catastrophic hemorrhage

Placental Abruption

This involves premature separation of a normally implanted placenta before delivery 3, 4:

The pathophysiology includes:

  • Maternal vascular malperfusion causing decidual vessel rupture and retroplacental hematoma formation
  • Decidual necrosis from chronic uteroplacental insufficiency
  • Acute vascular disruption from trauma, hypertension, or cocaine use
  • Ascending infection/acute deciduitis causing inflammatory-mediated placental separation 3

Recent evidence identifies ascending infection (chorioamnionitis) as independently associated with APH (OR 3.13), suggesting infection-mediated decidual inflammation and weakening as an underrecognized mechanism 3.

Risk Factor Pathways

Mechanical/Anatomic Factors

  • Previous cesarean section: Creates focal areas of deficient decidualization and abnormal vascularization
  • Anterior placentation with praevia: Increases hemorrhage risk 3.5-fold due to proximity to previous surgical scars 1
  • Multiparity: Cumulative endometrial damage from previous pregnancies
  • Advanced maternal age (35-39 years): Associated with declining endometrial quality 5

Vascular/Inflammatory Factors

  • Hypertensive disorders: Cause decidual vasculopathy and vessel rupture
  • Chorioamnionitis: Inflammatory cytokines weaken decidual-placental interface 3
  • Thrombophilia: Promotes microvascular thrombosis and placental infarction

Iatrogenic Factors

  • Previous uterine artery embolization: Dramatically increases APH risk (OR 11.7) through altered uterine vascular architecture 6

Clinical Implications of Pathogenesis

The pathophysiologic understanding directly informs risk stratification:

High-risk features predicting massive hemorrhage 1:

  • Complete placenta praevia covering os (OR 4.1)
  • Anterior placentation (OR 3.5)
  • Cervical length <31 mm (OR 16.4)
  • Three or more bleeding episodes (OR 27)
  • Partial absence of overlying myometrium (suggesting accreta) (OR 2.0) 6

In approximately 50% of APH cases, no definitive cause is identified despite investigation 7, 4, suggesting additional unrecognized pathophysiologic mechanisms or subclinical variants of known conditions.

Critical Pitfall

The poor correlation between clinical and pathological diagnosis of abruption (sensitivity 30.2%) means clinicians must maintain high suspicion even with equivocal findings 3. Histopathological examination is essential for understanding recurrence risk in subsequent pregnancies, as the underlying pathophysiology (vascular vs. infectious vs. mechanical) determines future management strategies.

References

Guideline

placenta praevia and placenta accreta: diagnosis and management: green-top guideline no. 27a.

BJOG : an international journal of obstetrics and gynaecology, 2019

Guideline

placenta accreta spectrum.

American Journal of Obstetrics and Gynecology, 2018

Research

Antepartum haemorrhage.

Journal of prenatal medicine, 2010

Research

Antepartum Hemorrhage: A Retrospective Analysis from a Northern Nigerian Teaching Hospital.

International journal of applied & basic medical research, 2017

Research

Ante-partum haemorrhage: an update.

Journal of obstetrics and gynaecology : the journal of the Institute of Obstetrics and Gynaecology, 2008

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.